Historically, I’ve viewed stocks as funny money. It’s not real until it’s converted into something you can use. Given the lack of utility for stocks, I’ve long preferred owning real…
gains
-
-
Investment
Gaming Stock Roblox Corporation (NYSE: RBLX) Gains on Updates to Expand Play, Give Creators the Game Engine and AI Tools
Roblox shares jumped to the NYSE top gainers list after the company unveiled new play, creation and monetization tools at its 12th annual Roblox Developers Conference. Investorideas.com (www.investorideas.com), a go-to…
-
Investment
Volatus Aerospace (TSX: FLT) Gains on Canadian Defence Contract for Tactical ISR Uncrewed Aircraft Systems
A five-year Government of Canada contract for up to 5,000 tactical ISR uncrewed aircraft systems sends Volatus to the TSX top gainers list. Investorideas.com (www.investorideas.com newswire) a trusted platform for…
-
Bitcoin (BTC) has struggled to flip $80,000 into support in recent days, but bulls’ real challenge is still to come, new research says. Key points: Bitcoin long-term holders add to…
-
The US Federal Reserve’s decision to hold interest rates steady while signaling a clear bias toward future hikes has propelled gold to new highs while exposing silver’s macroeconomic vulnerabilities. Following…
-
PUMP and PI are also well in the green on a daily scale. Bitcoin’s price failed at $65,000 earlier this week, and the subsequent correction pushed it south to…
-
Technology · Trading Alert NASDAQ: AMZN Amazon shares surge after second-quarter results show accelerating AWS growth and early payoff from AI infrastructure spending. …
-
Investment
AI Stock VisionWave (Nasdaq: VWAV) Sees Early Gains on Patent Filing with Multiple Defense Uses
VisionWave shares traded as high as $2.59 after the company’s DeepWave RF patent filing was framed around tunnel detection, landmine location, base security, and tactical operations. Investorideas.com (www.investorideas.com newswire), a…
-
Fresh Wall Street upgrades and growing confidence in Shopify’s AI assistant Sidekick sent shares up as much as 8.88% ahead of second-quarter results. Investorideas.com (www.investorideas.com newswire) a trusted platform for…
-
BeritK/iStock via Getty Images The US FDA has granted Fast Track designation to Acadia Pharmaceuticals’ (ACAD) remlifanserin in Alzheimer’s disease psychosis. The asset is currently in phase 2 for Lewy…
